Publications by authors named "Kristen Sweet"

Claim this Profile

Mentions over time

Mentions by platform

Video Views

1,335

Total Likes

68

Extended Reach

61,658

Social Features

12
G
Gluten-induced Neurocognitive Impairment: Results of a Nationwide Study.
Jessica B Edwards George, Babatunde Aideyan, Kayla Yates, Kristin N Voorhees, Jennifer O'Flynn, Kristen Sweet, Kate Avery, Alan Ehrlich, Alice Bast, Daniel A Leffler

J Clin Gastroenterol· August 2022

Videos about Article: user user

2 1 9 4 15

View All Article and Social Media Activity
G
Guselkumab Modulates Differentially Expressed Genes in Blood of Patients With Psoriatic Arthritis: Results from Two Phase 3, Randomized, Placebo-Controlled Trials.
Stefan Siebert, Kristen M Sweet, Christopher T Ritchlin, Elizabeth C Hsia, Alexa P Kollmeier

ACR Open Rheumatol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic and Molecular Distinctions Between Axial Psoriatic Arthritis and Radiographic Axial Spondyloarthritis: Post Hoc Analyses from Four Phase 3 Clinical Trials.
Arthur Kavanaugh, Xenofon Baraliakos, Sheng Gao, Warner Chen, Kristen Sweet

Adv Ther· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2).
Georg Schett, Matthew J Loza, Arumugam Palanichamy, Oliver FitzGerald, Christopher Ritchlin, Kristen Sweet

Rheumatol Ther· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Publisher Correction to: Collagen Turnover Biomarkers Associate with Active Psoriatic Arthritis and Decrease with Guselkumab Treatment in a Phase 3 Clinical Trial (DISCOVER-2).
Georg Schett, Matthew J Loza, Arumugam Palanichamy, Oliver FitzGerald, Christopher Ritchlin, Kristen Sweet

Rheumatol Ther· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of guselkumab on axial involvement in patients with active psoriatic arthritis and sacroiliitis: a post-hoc analysis of the phase 3 DISCOVER-1 and DISCOVER-2 studies.
Philip J Mease, Philip S Helliwell, Dafna D Gladman, Denis Poddubnyy, Xenofon Baraliakos, Kristen Sweet

Lancet Rheumatol· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guselkumab induces robust reduction in acute phase proteins and type 17 effector cytokines in active psoriatic arthritis: results from phase 3 trials.
Kristen Sweet, Qingxuan Song, Matthew J Loza, Iain B McInnes, Keying Ma

RMD Open· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Suppression of Serum Interferon-γ Levels as a Potential Measure of Response to Ustekinumab Treatment in Patients With Systemic Lupus Erythematosus.
Matteo Cesaroni, Loqmane Seridi, Matthew J Loza, Jessica Schreiter, Kristen Sweet

Arthritis Rheumatol· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prevalence, incidence, and distribution of human papillomavirus types in female sex workers in Kenya.
Kristen Sweet, Claire Bosire, Busola Sanusi, Carly J Sherrod, Jessie Kwatampora

Int J STD AIDS· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of ustekinumab on spondylitis-associated endpoints in TNFi-naïve active psoriatic arthritis patients with physician-reported spondylitis: pooled results from two phase 3, randomised, controlled trials.
Philip S Helliwell, Dafna D Gladman, Soumya D Chakravarty, Shelly Kafka, Chetan S Karyekar, Kristen Sweet

RMD Open· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sirukumab and adalimumab reduce power Doppler ultrasound signal in patients with rheumatoid arthritis by 4 weeks in a phase III trial.
Kristen Sweet, Bidisha Dasgupta, Dick de Vries, Ian Gourley, Benjamin Hsu

Ann Rheum Dis· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Responsiveness of Serum C-Reactive Protein, Interleukin-17A, and Interleukin-17F Levels to Ustekinumab in Psoriatic Arthritis: Lessons From Two Phase III, Multicenter, Double-Blind, Placebo-Controlled Trials.
Stefan Siebert, Kristen Sweet, Bidisha Dasgupta, Kim Campbell, Iain B McInnes

Arthritis Rheumatol· October 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Three Multicenter, Randomized, Double-Blind, Placebo-Controlled Studies Evaluating the Efficacy and Safety of Ustekinumab in Axial Spondyloarthritis.
Atul Deodhar, Lianne S Gensler, Joachim Sieper, Michael Clark, Cesar Calderon, Kristen Sweet

Arthritis Rheumatol· February 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral profiling identifies multiple subtypes of Kaposi's sarcoma.
Mina C Hosseinipour, Kristen M Sweet, Jie Xiong, Dan Namarika, Albert Mwafongo

mBio· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis